CLINICAL TRIALS PROFILE FOR SUMATRIPTAN SUCCINATE
✉ Email this page to a colleague
All Clinical Trials for sumatriptan succinate
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00329355 ↗ | Menstrual Migraine Treatment With TREXIMET (Formerly Known as TREXIMA) | Completed | GlaxoSmithKline | Phase 3 | 2006-05-01 | This study was designed to determine efficacy of TREXIMET (sumatriptan/naproxen sodium), formerly known as TREXIMA compared to placebo for the treatment of a menstrual migraine. |
NCT00329459 ↗ | Treximet (Sumatriptan/Naproxen Sodium), Formerly Known as TREXIMA, for Menstrual Migraine in Women With Dysmenorrhea | Completed | GlaxoSmithKline | Phase 3 | 2006-05-01 | This study was designed to determine efficacy of TREXIMA compared to placebo for the treatment of a menstrual migraine. |
NCT00356603 ↗ | Study Of Sumatriptan Succinate Injection Kit In Patients With Migraine or Cluster Headache In Japan | Completed | GlaxoSmithKline | Phase 3 | 2006-06-20 | This study will be conducted to collect cases treated by self-injection of sumatriptan 3mg kit product for the treatment of migraine or cluster headache attacks in clinical settings, to demonstrate the efficacy, and to examine patient acceptability (simplicity and usefulness) and rate of successful self-injection. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for sumatriptan succinate
Condition Name
Clinical Trial Locations for sumatriptan succinate
Trials by Country
Clinical Trial Progress for sumatriptan succinate
Clinical Trial Phase
Clinical Trial Sponsors for sumatriptan succinate
Sponsor Name